阻塞性睡眠呼吸暂停手术的代谢结局:范围综述
本范围综述检索PubMed、Embase、Web of Science和Cochrane Library数据库,评估阻塞性睡眠呼吸暂停手术代谢结局的现有证据。初检3484项研究,160项符合纳入标准,其中129项仅因报告术前和术后BMI被纳入;其余31项(1675名参与者)检查了其他代谢结局,多数研究显示C反应蛋白、TNF-α、IL-6和瘦素改善,但空腹血糖、胰岛素抵抗或HbA1c无变化。现有文献提示OSA手术与炎症标志物改善相关,但上气道刺激和骨骼手术的代谢结局研究匮乏。
要点
- 31项研究(1675名参与者)检查了BMI以外的代谢结局,手术类别包括单独软组织手术(58.1%)、软组织联合鼻或骨骼手术(32.3%)、上气道刺激(6.5%)和单独骨骼手术(3.2%)。
- 最常检查的代谢结局为C反应蛋白(45.1%)、血脂谱(45.1%)、TNF-α和IL-6(25.8%)、空腹血糖(25.8%)、瘦素(22.6%)、HbA1c(19.4%)和胰岛素抵抗(16.1%)。
- 多数研究显示C反应蛋白、TNF-α、IL-6和瘦素改善,但空腹血糖、胰岛素抵抗或HbA1c无变化;无研究将BMI作为主要结局。
核心结论
- 现有文献提示阻塞性睡眠呼吸暂停手术与炎症标志物改善相关。
- 上气道刺激和骨骼手术的代谢结局研究匮乏,凸显这些手术的知识空白。
研究设计与样本
- 范围综述,检索PubMed、Embase、Web of Science和Cochrane Library数据库。
- 检索策略由本机构资深信息学家制定。
- 初检3484项研究,160项符合纳入标准;129项仅因报告术前和术后BMI被纳入。
- 其余31项研究(n=1675名参与者)检查了其他代谢结局,由三名审查者进行标题、摘要和全文筛选并做叙述性综合。
主要发现
- 31项研究中,手术类别包括单独软组织手术(58.1%)、软组织联合鼻或骨骼手术(32.3%)、上气道刺激(6.5%)和单独骨骼手术(3.2%)。
- 最常检查的代谢结局为C反应蛋白(45.1%)、血脂谱(45.1%)、TNF-α和IL-6(25.8%)、空腹血糖(25.8%)、瘦素(22.6%)、HbA1c(19.4%)和胰岛素抵抗(16.1%)。
- 多数研究显示C反应蛋白、TNF-α、IL-6和瘦素改善,但空腹血糖、胰岛素抵抗或HbA1c无变化。
- 无纳入研究将BMI作为主要结局。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate the available evidence on the metabolic outcomes of obstructive sleep apnea (OSA) surgery and identify gaps in the current literature. DATA SOURCES: A literature search was performed using PubMed, Embase, Web of Science, and Cochrane Library databases. REVIEW METHODS: Search strategy was developed with a senior informationist at our institution. Metabolic measures of interest included insulin resistance, fasting glucose, hemoglobin A1C (HbA1c), inflammatory markers, adipokines, lipid profiles, and body mass index (BMI). Title, abstract, and full-text screening were performed by three reviewers with subsequent narrative synthesis. RESULTS: 3484 studies were initially identified, with 160 meeting inclusion criteria. 129 studies were included solely due to reporting of pre- and post-operative BMIs. The remaining 31 studies (n = 1675 participants) examined other metabolic outcomes and included various categories of OSA surgery: soft tissue surgery alone (58.1%) or in combination with nasal or skeletal surgery (32.3%), upper airway stimulation (6.5%), and skeletal surgery alone (3.2%). Within the 31 studies, the most commonly examined metabolic outcomes were C-reactive protein (CRP, 45.1%), lipid profiles (45.1%), TNF-α and IL-6 (25.8%), fasting glucose (25.8%), leptin (22.6%), HbA1c (19.4%), and insulin resistance (16.1%). Most studies demonstrated improvements in CRP, TNF-α, IL-6, and leptin, but no changes in fasting glucose, insulin resistance, or HbA1c. None of the included studies examined BMI as a primary outcome. CONCLUSIONS: The existing literature suggests that OSA surgery is associated with improvements in inflammatory markers. The paucity of studies on the metabolic outcomes of upper airway stimulation and skeletal surgery highlights knowledge gaps for these OSA surgeries.
引用
- Kutler RB, Caplan IF, Jelic S, et al. The Metabolic Outcomes of Obstructive Sleep Apnea Surgery: A Scoping Review. Laryngoscope. 2025. PMID: 40353761. doi:10.1002/lary.32255
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。